{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6ac37ae452a5384444c70cea/6ad4940a18a03bedba1c493c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Vad är riskerna med Ozempic?","description":"<p>Det är 2026 och Ozempic, Mounjaro och retatrutid får människor att rasa i vikt – men verkar också minska risken för allt från reumatism till våldsamma brott – och kanske till och med förlänga livet. <strong>Har vi hittat en mirakelmedicin som alla borde ta?</strong></p><p><br></p><p>Eller finns det en hake? För samtidigt som allt fler tar viktmediciner växer frågorna om biverkningarna. Håravfall, hjärnskador och blindhet diskuteras, såväl som att totalt tappa lusten till sex, mat, och allt annat som gör livet roligt?</p><p><br></p><p><strong>Källor:</strong></p><p><a href=\"https://pubmed.ncbi.nlm.nih.gov/37952131/\" rel=\"noopener noreferrer\" target=\"_blank\">Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes</a></p><p><a href=\"https://www.nejm.org/doi/10.1056/NEJMoa2403347\" rel=\"noopener noreferrer\" target=\"_blank\">Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes</a></p><p><a href=\"https://doi.org/10.1001/jamanetworkopen.2026.12133\" rel=\"noopener noreferrer\" target=\"_blank\">Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer</a></p><p><a href=\"https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2829811\" rel=\"noopener noreferrer\" target=\"_blank\">Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial</a></p><p><a href=\"https://onlinelibrary.wiley.com/doi/10.1111/1745-9125.70058\" rel=\"noopener noreferrer\" target=\"_blank\">Glucagon-Like Peptide-1 Receptor Agonist Use and Violent Crime Among US Adults</a></p><p><a href=\"https://www.kff.org/health-costs/public-opinion-on-prescription-drugs-and-their-prices/\" rel=\"noopener noreferrer\" target=\"_blank\">KFF Health Tracking Poll: GLP-1 Use and Affordability</a></p><p><a href=\"https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp\" rel=\"noopener noreferrer\" target=\"_blank\">FDA Requests Removal of Suicidal Behavior and Ideation Warning From GLP-1 Medications</a></p><p><a href=\"https://pubmed.ncbi.nlm.nih.gov/42518361/\" rel=\"noopener noreferrer\" target=\"_blank\">Resolution of Anhedonia-Like Symptoms in Patients Treated for Obesity With Tirzepatide: A Three-Case Series</a></p><p><a href=\"https://www.nature.com/articles/s41586-026-10940-7\" rel=\"noopener noreferrer\" target=\"_blank\">Late-Life Semaglutide Treatment Slows Ageing and Extends Lifespan in Female Mice</a></p><p><a href=\"https://www.ema.europa.eu/en/news/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy\" rel=\"noopener noreferrer\" target=\"_blank\">PRAC Concludes Eye Condition NAION Is a Very Rare Side Effect of Semaglutide Medicines</a></p><p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8089287/\" rel=\"noopener noreferrer\" target=\"_blank\">Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study</a></p><p><a href=\"https://pubmed.ncbi.nlm.nih.gov/41666927/\" rel=\"noopener noreferrer\" target=\"_blank\">Semaglutide Ameliorates Osteoarthritis Progression Through a Weight Loss-Independent Metabolic Restoration Mechanism</a></p><p><a href=\"https://pubmed.ncbi.nlm.nih.gov/41865758/\" rel=\"noopener noreferrer\" target=\"_blank\">Efficacy and Safety of Oral Semaglutide in Early-Stage Symptomatic Alzheimer&#39;s Disease (evoke and evoke+)</a></p><p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4995441/\" rel=\"noopener noreferrer\" target=\"_blank\">Body-Mass Index and All-Cause Mortality: Individual-Participant-Data Meta-Analysis of 239 Prospective Studies</a></p><p><br></p><p><strong>Kapitel:</strong></p><p>00:00 Godis, Ozempic och svarta marknaden</p><p>06:44 Varför provocerar viktmedicin?</p><p>14:05 Kan Ozempic förebygga sjukdomar?</p><p>18:50 Slutar man vilja äta och dricka?</p><p>24:47 Kan Ozempic ta bort livslusten?</p><p>28:47 Blindhet och andra biverkningar</p><p>33:11 Kan Ozempic förlänga livet?</p><p>35:15 Slutsatsen: Borde alla ta Ozempic?</p>","author_name":"Erik Galli"}